<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang J</submitter><funding>M.S.I. Foundation</funding><pagination>e056543</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8772408</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>It remains unclear whether vitamin D status is related to cancer risk. We examined this relationship using laboratory, administrative and survey data.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Setting&lt;/h4>All care settings within Calgary, Alberta, Canada and surrounding rural communities.&lt;h4>Participants&lt;/h4>Patients tested for serum 25-hydroxyvitamin D from 2009 to 2013 without a past cancer diagnosis but with an ECG and body mass index ±3 months from testing were included. Age, sex, mean hours of daylight during month of testing were linked to census dissemination area-level indicators of socioeconomic status measured in 2011.&lt;h4>Primary and secondary outcome measures&lt;/h4>Hospital discharge diagnoses for any cancer, major cancer (colorectal, breast, lung, prostate, </pubmed_abstract><journal>BMJ open</journal><pubmed_title>Serum 25-hydroxyvitamin D and risk of cancer in a large community population under investigation for cardiovascular disease: a retrospective cohort study.</pubmed_title><pmcid>PMC8772408</pmcid><funding_grant_id>871</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Naugler CT</pubmed_authors><pubmed_authors>de Koning L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum 25-hydroxyvitamin D and risk of cancer in a large community population under investigation for cardiovascular disease: a retrospective cohort study.</name><description>&lt;h4>Objectives&lt;/h4>It remains unclear whether vitamin D status is related to cancer risk. We examined this relationship using laboratory, administrative and survey data.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Setting&lt;/h4>All care settings within Calgary, Alberta, Canada and surrounding rural communities.&lt;h4>Participants&lt;/h4>Patients tested for serum 25-hydroxyvitamin D from 2009 to 2013 without a past cancer diagnosis but with an ECG and body mass index ±3 months from testing were included. Age, sex, mean hours of daylight during month of testing were linked to census dissemination area-level indicators of socioeconomic status measured in 2011.&lt;h4>Primary and secondary outcome measures&lt;/h4>Hospital discharge diagnoses for any cancer, major cancer (colorectal, breast, lung, prostate, </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-19T15:46:04.587Z</modification><creation>2025-04-19T15:46:04.587Z</creation></dates><accession>S-EPMC8772408</accession><cross_references><pubmed>35046006</pubmed><doi>10.1136/bmjopen-2021-056543</doi></cross_references></HashMap>